Antibiotic prophylaxis after variceal hemorrhage reduces incidence of early rebleeding

Hepato-Gastroenterology

Volumn 51, Issue 56, 2004, Pages 541-546

  Pohl, Jürgen ^a,b   Pollmann, Klaus ^a   Sauer, Peter ^a   Ring, Axel ^a   Stremmel, Wolfgang ^a   Schlenker, Thorsten ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Antibiotic prophylaxis; Rebleeding Infection; Variceal hemorrhage

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFOTAXIME; CIPROFLOXACIN; OCTREOTIDE; TERLIPRESSIN;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; SEPSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 1842535310     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: a meta-analytic review. Hepatology 1995; 22:332-354.
2. Burroughs AK, Mezzanote G, Phillips A, et al: Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology 1989; 9:801-807.
3. Ben-Ari Z, Cardin F, Wannamethee G, et al: Prognostic significance of endoscopic active bleeding and early rebleeding from oesophageal varices. J Hepatol 1996; 20:92. (Abstract)
4. Pauwels A, Mostefa-Kara N, Debenes B, et al: Antimicrobial prophylaxis after gastrointestinal hemorrage for cirrhotic patients with a high risk of infection. Hepatology 1996; 24:802-806.
5. Bernard B, Cadranel JF, Valla D, et al: Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995; 108:1828-1834.
6. Blaise M, Pateron D, Trinchet JC, et al: Systemic antibiotic therapy prevents bacterial infections in cirrhotic patients with gastrointestinal hemorrhage. Hepatology 1994; 20:34-38.
7. Soriano G, Guarner C, Tomas A, et al: Norfloxacin prevents bacterial infections in cirrhotics with gastrointestinal bleeding. Gastroenterology 1992; 103:1267-1272.
8. Deschenes M, Villeneuve JP: Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol 1999; 94:2193-2197.
9. Rimola A, Soto R, Bory F, et al: Reticuloendothelial system phagocyte activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology 1984; 4:53-58.
10. Bleichner G, Boulanger R, Squara P, et al: Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 1986; 73:724-726.
11. Barnes PF, Arevalo C, Chan LS, et al: A prospective evaluation of bacteremic patients with chronic liver disease. Hepatology 1988; 8:1099-1103.
12. Hsieh WJ, Lin HC, Hwang SJ, et al: The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998; 93:962-966.
13. Soares-Weiser K, Brezis M, Tur-Kaspa R, et al: Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding. The Cochrane Library 2002, issue 1.
14. Goulis J, Armonis A, Patch D, et al: Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal haemorrhage. Hepatology 1998; 27:1207-1212.
15. De Franchis R: Updating consensus in portal hypertension: report of the Baveno III consensus workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33:846-852.
16. Garner JS, Jarvis WR, Emori TG, et al: CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140.
17. Sauerbruch T, Weinzieri M, Ansari H, et al: Injection sclerotherapy of oesophageal variceal hemorrhage: a prospective long-term follow-up study. Endoscopy 1987; 19:181-184.
18. Bernard B, Grange JD, Nguyen Khac E, et al: Antibiotic prophylaxis (AbP) for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding (GB): a meta-analysis. Hepatology 1999; 29:1655-1661.
19. Avgerinos A, Armonis A: Balloon tamponade technique and efficiency in variceal haemorrhage. Scand J Gastroenterol 1994; 207:11-15.